01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. November 17, 2020 – Posted in: Blog, Venture Life Group (VLG)

  Alan Green talks to Venture Life Group (AIM: VLG) CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. Sharon also discusses the group progress to date in 2020, and summarises the current investment proposition for investors

Continue reading

(No title) November 16, 2020 – Posted in: Venture Life Group (VLG)

16th November, 2020 VENTURE LIFE GROUP PLC (“Venture Life” “VLG” or the “Company”) Cardiff University’s published in-vitro study reports two CPC-based mouthwashes completely eradicate SARS-CoV-2 (COVID-19) within a 30 second exposure Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, announced on 24 August 2020 its involvement in a UK-led clinical trial, with one of its key oral care brands containing the powerful Cetylpyridinium Chloride (“CPC”) technology, on those affected with COVID-19.…

Continue reading

Venture Life included in London Stock Exchange Group’s ‘1000 Companies to Inspire Britain’ 2020 report for a fifth consecutive year November 3, 2020 – Posted in: Venture Life Group (VLG)

3rd November 2020 Venture Life Group plc (“Venture Life” or the “Company”) Venture Life included in London Stock Exchange Group’s ‘1000 Companies to Inspire Britain’ 2020 report for a fifth consecutive year   Venture Life (AIM: VLG), the international consumer self-care company focused on developing, manufacturing and commercialising products for the self-care market, announces that it has been recognised in the London Stock Exchange’s ‘1000 Companies to Inspire Britain 2020’ report for a fifth consecutive year.  The report recognises…

Continue reading

Venture Life Group #VLG – CEO Jerry Randall discusses today’s interim results & trading update September 24, 2020 – Posted in: Venture Life Group (VLG)

Alan Green talks to Venture Life Group (VLG) CEO Jerry Randall about the company’s interim results. Jerry goes through the numbers and commercial developments for the period, before discussing post period-end developments, including an independent study at Cardiff University on the effects on Dentyl Dual Action mouthwash on patients affected by COVID-19. Jerry explains the resilience and adaptability of the Venture Life business model in countering the challenge of the COVID lockdown, and highlights how…

Continue reading

Venture Life Group VLG – Trading Update July 20th 2020 July 20, 2020 – Posted in: Venture Life Group (VLG)

Alan Green talks to Venture Life Group (VLG) CEO Jerry Randall about today’s trading update. Jerry provides an overview of the VLG offering, and then discusses the financial and commercial highlights in today’s statement. Looking forward Jerry covers VLG’s strong financial position, and how non-dilutive funding will be used for further acquisitions, some of which (subject to Covid restrictions), may arrive before Christmas 2020. Jerry also provides key points for investors going forward. 1) Earnings…

Continue reading

Venture Life Group (AIM: VLG) – Alan Green talks to CEO Jerry Randall June 9, 2020 – Posted in: Venture Life Group (VLG)

Alan Green talks Jerry Randall, CEO of Venture Life Group (AIM: VLG). Jerry provides an overview of the company operating structure and strategy, and then covers today’s trading statement, going into detail on the very strong trading that will see the company ‘comfortably exceed market expectations’ for the year. Jerry covers the group’s commercial relationships and partners, provides detail on the strong funding position and provides an outlook for value inflection points going forward.

Continue reading